<DOC>
	<DOCNO>NCT01592318</DOCNO>
	<brief_summary>This randomize , open-label , crossover study evaluate relative bioavailability ritonavir-boosted danoprevir fix dose combination tablet ( FDC ) compare ad hoc combination reference tablet danoprevir ritonavir healthy volunteer . Subjects randomize 1 6 treatment sequence receive single oral dos either FDC danoprevir ritonavir danoprevir ritonavir separate tablet . In crossover design , subject participate 3 study period least 7-day washout period . In Part 2 , single dose administration film-coated FDCs compare reference tablet .</brief_summary>
	<brief_title>A Study The Relative Bioavailability Ritonavir-Boosted Danoprevir Fixed Dose Combination Tablets Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Lactams</mesh_term>
	<criteria>Male female volunteer , 18 55 year age Body weight &gt; /= 50.0 kg Body mass index ( BMI ) 18.0 32.0 kg/m2 Healthy nonsmoking subject . Healthy status define absence evidence active chronic disease follow detailed medical surgical history complete physical examination Medical history without major , recent , ongoing pathology Females childbearing potential male female partner childbearing potential must agree use 2 form contraception , 1 must barrier method , study 90 day last drug administration Pregnant lactate woman male female partner pregnant lactate Any history clinically significant cardiovascular cerebrovascular disease , hypertension , and/or infection Positive result drug abuse screen prior admission clinical site study period Positive hepatitis B , hepatitis C HIV infection Current smoker subject discontinue smoke less 6 month prior first dose study medication Use hormonal contraceptive ( e.g . birth control pill , patch , injectable , implantable device ) within 30 day first dose study medication Use investigational drug device within 30 day first dose study medication ( 6 month biologic therapy ) 5 halflives investigational drug , whichever long History drugrelated allergic reaction hepatotoxicity History ( within 3 month screen ) alcohol consumption exceed 2 standard drink per day average</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>